Macroaxis: Personalized Investing
Simple Personalized Investing

SP 500   1,655   13.81  Index Moved Down -0.83%
AMPI3 AMBV4 AMBV3 AMIL3 Semiconductor Apparel Compulsion Momentum 
United States GSPC USD ...  |  Investing Toolset


Processing
Collecting data for IMBI4

DOC IMBITUBA performance

 
 Companies |  Insiders  | Dashboard  
     

DOC IMBITUBAPN

Stock@Sao Paolo Stock Exchange 
Brazil BRL
   
Use DOC IMBITUBAPN (#BRIMBIACNPR1BR) performance together with your other stock asset holdings to protect against small markets fluctuations as well as to check it against diversification policy that fits your risk preferences.  Optimize Portfolio
Investment horizon: 
  30 Days    Login   to change

Relative Risk vs. Return Landscape

If you would invest  52.00  in DOC IMBITUBAPN on April 23, 2013 and sell it today you would lose (1.00) from holding DOC IMBITUBAPN or give up 1.92% of portfolio value over 30 days. DOC IMBITUBAPN is generating 0.61% of daily returns and assumes 7.18% volatility on return distribution over the 30 days horizon. Simply put, 94% of equities are less volatile than DOC IMBITUBAPN and 65% of equity instruments are likely to generate higher returns than the company over the next 30 trading days.
Daily Expected Return (%)
 
Change Benchmark   Risk [Daily Volatility] (%)
Assuming 30 trading days horizon, DOC IMBITUBAPN is expected to generate 12.6 times more return on investment than the market. However, the company is 12.6 times more volatile than its market benchmark. It trades about 0.08 of its potential returns per unit of risk. The S&P 500 is currently generating roughly 0.39 per unit of risk.

DOC IMBITUBA Operating Margin

Based on recorded statements DOC IMBITUBAPN has Operating Margin of 0.0%. This indicator is about the same for average (which is currently at 0.0) sector, and about the same as Operating Margin (which currently averages 0.0) industry, This indicator is about the same for all stocks average (which is currently at 0.0).
A good Operating Margin is required for a company to be able to pay for its fixed costs or pay out its debt which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against firm's competitors.
DOC IMBITUBA
Performance
4
Out Of
100
Over 30
Days
96% of all equities and portfolios perform better than DOC IMBITUBAPN. Compared with the overall equity markets, risk-adjusted returns on investments in DOC IMBITUBAPN are ranked lower than 4 (%) of all global equities and portfolios over the last 30 days.
Embed widgets for DOC IMBITUBA
Financial widgets and gadgets
Live stock tickers for equities

1 Month Efficiency (a.k Sharpe Ratio) ...

0.09

Best
Portfolio
Best
Equity
Good Returns
Average ReturnsIMBI4
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative Returns

Estimated Market Risk

 7.18
  actual daily
 
 6 %
of total potential
 
Market Risk score

Expected Return

 0.61
  actual daily
 
 35 %
of total potential
 
Expected Return score

Risk-Adjusted Return

 0.09
  actual daily
 
 4 %
of total potential
 
Risk-Adjusted Return score
Based on monthly moving average DOC IMBITUBA is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of DOC IMBITUBA by adding it to a well-diversified portfolio.
Follow DOC IMBITUBA Performance with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add DOC IMBITUBA to your reader
 

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium